Antidepressants dramatically raise risk of cataracts
(NaturalNews) Of the 35 million Americans who are age 65 or older, the National Institutes of Health (NIH) claims about 7 million of them suffer from clinical depression -- and millions are on the prescription antidepressant drugs known as selective serotonin reuptake inhibitors (SSRIs) such as Prozac, Paxil, Lexapro and Zoloft. Hyped by Big Pharma as the way to solve depression problems in all age groups, these medications come with a litany of serious side effects, including some that are particularly dangerous for elders.For example, a University of Minnesota study found SSRIs increase the rate of bone loss in older men and women. And now there's even more reason for seniors to be wary of taking SSRIs. New research just published in Ophthalmology, the journal of the American Academy of ...div id=medwormpbiMedWorm Message:/i/b Please support the a href=http://www.doctorsinchains.org/ target=_blankDoctors In Chains/a campaign for the a href=http://www.doctorsinchains.org/medics/a tortured and sentenced for up to 15 years in a href=http://www.doctorsinchains.org/Bahrain/a. a href=https://twitter.com/#!/search/%23FreeDoctors#FreeDoctors/a/p/div
FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
PALO ALTO, Calif., Dec. 21 (HSMN NewsFeed) -- Today, Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced that the U.S. Food and Drug Administration (FDA) has issued an approvable letter for Once-A-Day LUVOXreg; CR (fluvoxamine maleate) Extended-Release... Biopharmaceuticals, FDAJazz Pharmaceuticals, Solvay Pharmaceuticals, LUVOX CR, LUVOX, fluvoxamine, OCD (Source: HSMN NewsFeed)
